Kala Pharmaceuticals Inc. (KALA)
6.06
-0.26 (-4.11%)
At close: Mar 28, 2025, 3:59 PM
6.27
3.54%
Pre-market: Mar 31, 2025, 04:11 AM EDT
Kala Pharmaceuticals Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Cash & Equivalents | 50.9M | 70.5M | 92.14M | 77.26M | 85.45M | 170.9M | 114.56M | 45.47M | 5.76M | 10.62M | 5.34M |
| Short-Term Investments | n/a | n/a | n/a | 76.28M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | 301K | 462K | 1.46M | 12.99M | 12.58M | 12.21M | 134K | 109K | 109K | 109K | 194K |
| Other Long-Term Assets | n/a | n/a | 9.58M | 6.22M | 3.78M | n/a | n/a | n/a | n/a | -1 | n/a |
| Receivables | 236K | 6.5M | 17.45M | 9.85M | 13.1M | 1.03M | n/a | n/a | n/a | 38K | 303K |
| Inventory | n/a | 7.67M | 8.64M | 5.23M | 4.65M | 4.09M | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 1.74M | 8.95M | 6.14M | 2.76M | 2.29M | 1.01M | 648K | 154K | 110K | 120K | 322K |
| Total Current Assets | 52.87M | 85.94M | 124.37M | 171.38M | 105.48M | 177.03M | 115.21M | 45.63M | 7.6M | 10.78M | 5.97M |
| Property-Plant & Equipment | 2.78M | 416K | 4.02M | 31.02M | 32.48M | 31.73M | 786K | 594K | 738K | 835K | 911K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 3.08M | 878K | 15.06M | 50.23M | 48.84M | 43.94M | 920K | 703K | 847K | 944K | 1.1M |
| Total Assets | 55.95M | 86.82M | 139.43M | 221.61M | 154.32M | 220.97M | 116.13M | 46.33M | 8.45M | 11.72M | 7.07M |
| Account Payables | 919K | 2.35M | 2.78M | 1.72M | 2.52M | 5.45M | 1.2M | 997K | 1.4M | 429K | 436K |
| Deferred Revenue | 1.07M | 4.19M | 28M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 200K |
| Short-Term Debt | 334K | 5.03M | 1.42M | 3.06M | 2.65M | 926K | 7.06M | 556K | 2M | n/a | 4.16M |
| Other Current Liabilities | 6.02M | 14.12M | 33.22M | 17.44M | 19.6M | 10.64M | 6.19M | 3.99M | 2.1M | 2.52M | 786K |
| Total Current Liabilities | 8.35M | 25.68M | 37.42M | 22.23M | 24.77M | 17.01M | 14.46M | 5.55M | 5.51M | 2.95M | 5.58M |
| Long-Term Debt | 35.99M | 37.94M | 79.48M | 99.39M | 99.86M | 98.98M | 11.99M | 9.1M | 7.79M | 4.66M | 513K |
| Other Long-Term Liabilities | 4.11M | 4.22M | 5.72M | n/a | n/a | n/a | 9K | 119.45M | 51.81M | 843K | 773K |
| Total Long-Term Liabilities | 40.1M | 42.16M | 85.2M | 99.39M | 99.86M | 98.98M | 12M | 128.54M | 59.6M | 5.51M | 1.29M |
| Total Liabilities | 48.45M | 67.85M | 122.62M | 121.61M | 124.63M | 115.98M | 26.45M | 134.09M | 65.11M | 8.46M | 6.87M |
| Total Debt | 36.32M | 42.95M | 80.19M | 100.92M | 101.18M | 99.44M | 18.65M | 9.65M | 9.79M | 4.66M | 4.67M |
| Common Stock | 3K | 2K | 66K | 59K | 36K | 34K | 25K | 1K | 1K | 5K | 5K |
| Retained Earnings | -629.41M | -587.21M | -542.39M | -399.78M | -295.46M | -201.11M | -134.37M | -92.14M | -58.97M | -42.29M | -22.93M |
| Comprehensive Income | n/a | n/a | n/a | 4K | n/a | -1.82M | -1.54M | -1.32M | -1.02M | n/a | n/a |
| Shareholders Equity | 7.5M | 18.97M | 16.8M | 100M | 29.69M | 104.99M | 89.68M | -87.76M | -56.66M | 3.26M | 202K |
| Total Investments | 301K | 462K | 1.46M | 76.28M | 12.58M | 12.21M | 134K | 109K | 109K | 109K | 194K |